Inventor
Bjorn L. MILLARD
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,122,819Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant202411,879,002Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof202411,155,593Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A52021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to SILVER CREEK PHARMACEUTICALS INC (3)· patent assignee history
2021–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SILVER CREEK PHARMACEUTICALS INC | 3 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2021–2024 |